{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T02:39:20Z","timestamp":1768790360711,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003549","name":"Orsz\u00e1gos Tudom\u00e1nyos Kutat\u00e1si Alapprogramok (HU)","doi-asserted-by":"publisher","award":["PD100245"],"award-info":[{"award-number":["PD100245"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"name":"J\u00e1nos Bolyai Research Scholarship of the Hungarian Academy of Sciences"},{"DOI":"10.13039\/501100004895","name":"European Social Fund (BE)","doi-asserted-by":"publisher","award":["T\u00c1MOP 4.2.4. A\/1-11-1-2012-0001 \u2019National Excellence Program\u2019"],"award-info":[{"award-number":["T\u00c1MOP 4.2.4. A\/1-11-1-2012-0001 \u2019National Excellence Program\u2019"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12933-015-0309-x","type":"journal-article","created":{"date-parts":[[2015,10,31]],"date-time":"2015-10-31T02:52:56Z","timestamp":1446259976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus"],"prefix":"10.1186","volume":"14","author":[{"given":"Csaba","family":"M\u00e1ty\u00e1s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal\u00e1zs Tam\u00e1s","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Ol\u00e1h","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Hidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ede","family":"Birtalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalma","family":"Kellermayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mih\u00e1ly","family":"Ruppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevil","family":"Korkmaz-Ic\u00f6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"K\u00f6k\u00e9ny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eszter M\u00e1ria","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9la","family":"Merkely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Radovits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,31]]},"reference":[{"key":"309_CR1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","volume":"142","author":"K Huynh","year":"2014","unstructured":"Huynh K, Bernardo BC, McMullen JR, Ritchie RH. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther. 2014;142:375\u2013415.","journal-title":"Pharmacol Ther"},{"key":"309_CR2","doi-asserted-by":"crossref","first-page":"H125","DOI":"10.1152\/ajpheart.00165.2009","volume":"297","author":"T Radovits","year":"2009","unstructured":"Radovits T, Korkmaz S, Loganathan S, et al. Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol. 2009;297:H125\u201333.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"309_CR3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1476-5381.2008.00098.x","volume":"156","author":"T Radovits","year":"2009","unstructured":"Radovits T, Bomicke T, Kokeny G, et al. The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus. Br J Pharmacol. 2009;156:909\u201319.","journal-title":"Br J Pharmacol"},{"key":"309_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diacare.24.1.5","volume":"24","author":"P Poirier","year":"2001","unstructured":"Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001;24:5\u201310.","journal-title":"Diabetes Care"},{"key":"309_CR5","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0735-1097(99)00436-2","volume":"34","author":"II Joffe","year":"1999","unstructured":"Joffe II, Travers KE, Perreault-Micale CL, et al. Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway. J Am Coll Cardiol. 1999;34:2111\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"309_CR6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0828-282X(06)70914-X","volume":"22","author":"V Sharma","year":"2006","unstructured":"Sharma V, McNeill JH. Diabetic cardiomyopathy: where are we 40\u00a0years later? Can J Cardiol. 2006;22:305\u20138.","journal-title":"Can J Cardiol"},{"key":"309_CR7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1475-2840-12-49","volume":"12","author":"E Mourmoura","year":"2013","unstructured":"Mourmoura E, Vial G, Laillet B, et al. Preserved endothelium-dependent dilatation of the coronary microvasculature at the early phase of diabetes mellitus despite the increased oxidative stress and depressed cardiac mechanical function ex vivo. Cardiovasc Diabetol. 2013;12:49.","journal-title":"Cardiovasc Diabetol"},{"key":"309_CR8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1475-2840-12-111","volume":"12","author":"JT Pearson","year":"2013","unstructured":"Pearson JT, Jenkins MJ, Edgley AJ, et al. Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation. Cardiovasc Diabetol. 2013;12:111.","journal-title":"Cardiovasc Diabetol"},{"key":"309_CR9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.freeradbiomed.2006.06.007","volume":"41","author":"L Cai","year":"2006","unstructured":"Cai L. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy. Free Radic Biol Med. 2006;41:851\u201361.","journal-title":"Free Radic Biol Med"},{"key":"309_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","volume":"43","author":"S Moncada","year":"1991","unstructured":"Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109\u201342.","journal-title":"Pharmacol Rev"},{"key":"309_CR11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2013.04.012","volume":"710","author":"T Radovits","year":"2013","unstructured":"Radovits T, Arif R, Bomicke T, et al. Vascular dysfunction induced by hypochlorite is improved by the selective phosphodiesterase-5-inhibitor vardenafil. Eur J Pharmacol. 2013;710:110\u20139.","journal-title":"Eur J Pharmacol"},{"key":"309_CR12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ejcts.2009.03.065","volume":"36","author":"G Szabo","year":"2009","unstructured":"Szabo G, Radovits T, Veres G, et al. Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass. Eur J Cardiothorac Surg. 2009;36:657\u201364.","journal-title":"Eur J Cardiothorac Surg"},{"key":"309_CR13","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jtcvs.2008.10.016","volume":"137","author":"K Hirschberg","year":"2009","unstructured":"Hirschberg K, Radovits T, Loganathan S, et al. Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat carotid arteries after surgical endarterectomy. J Thorac Cardiovasc Surg. 2009;137:1508\u201314.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"309_CR14","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1097\/TP.0b013e31818aa34e","volume":"86","author":"S Loganathan","year":"2008","unstructured":"Loganathan S, Radovits T, Hirschberg K, et al. Effects of selective phosphodiesterase-5-inhibition on myocardial contractility and reperfusion injury after heart transplantation. Transplantation. 2008;86:1414\u20138.","journal-title":"Transplantation"},{"key":"309_CR15","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.jacc.2011.09.086","volume":"59","author":"RC Kukreja","year":"2012","unstructured":"Kukreja RC, Salloum FN, Das A. Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection. J Am Coll Cardiol. 2012;59:1921\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"309_CR16","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/sj.bjp.0707459","volume":"153","author":"A Schafer","year":"2008","unstructured":"Schafer A, Fraccarollo D, Pfortsch S, et al. Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus. Br J Pharmacol. 2008;153:886\u201393.","journal-title":"Br J Pharmacol"},{"key":"309_CR17","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","volume":"116","author":"JP Stasch","year":"2006","unstructured":"Stasch JP, Schmidt PM, Nedvetsky PI, et al. Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. J Clin Invest. 2006;116:2552\u201361.","journal-title":"J Clin Invest"},{"key":"309_CR18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.109.870774","volume":"120","author":"S Korkmaz","year":"2009","unstructured":"Korkmaz S, Radovits T, Barnucz E, et al. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury. Circulation. 2009;120:677\u201386.","journal-title":"Circulation"},{"key":"309_CR19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejcts.2010.05.025","volume":"39","author":"T Radovits","year":"2011","unstructured":"Radovits T, Korkmaz S, Miesel-Groschel C, et al. Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass. Eur J Cardiothorac Surg. 2011;39:248\u201355.","journal-title":"Eur J Cardiothorac Surg"},{"key":"309_CR20","doi-asserted-by":"crossref","first-page":"H1347","DOI":"10.1152\/ajpheart.00544.2011","volume":"302","author":"FN Salloum","year":"2012","unstructured":"Salloum FN, Das A, Samidurai A, et al. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia\/reperfusion injury: role of hydrogen sulfide. Am J Physiol Heart Circ Physiol. 2012;302:H1347\u201354.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"309_CR21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1074248412455696","volume":"18","author":"S Korkmaz","year":"2013","unstructured":"Korkmaz S, Loganathan S, Mikles B, et al. Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta. J Cardiovasc Pharmacol Ther. 2013;18:70\u20137.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"309_CR22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ijcard.2012.01.032","volume":"167","author":"K Hirschberg","year":"2013","unstructured":"Hirschberg K, Tarcea V, Pali S, et al. Cinaciguat prevents neointima formation after arterial injury by decreasing vascular smooth muscle cell migration and proliferation. Int J Cardiol. 2013;167:470\u20137.","journal-title":"Int J Cardiol"},{"key":"309_CR23","doi-asserted-by":"crossref","first-page":"e44481","DOI":"10.1371\/journal.pone.0044481","volume":"7","author":"JC Irvine","year":"2012","unstructured":"Irvine JC, Ganthavee V, Love JE, et al. The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophy. PLoS One. 2012;7:e44481.","journal-title":"PLoS One"},{"key":"309_CR24","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1177\/0091270008322906","volume":"48","author":"R Frey","year":"2008","unstructured":"Frey R, Muck W, Unger S, Artmeier-Brandt U, Weimann G, Wensing G. Pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in healthy male volunteers. J Clin Pharmacol. 2008;48:1400\u201310.","journal-title":"J Clin Pharmacol"},{"key":"309_CR25","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/CIRCULATIONAHA.108.800292","volume":"119","author":"H Lapp","year":"2009","unstructured":"Lapp H, Mitrovic V, Franz N, et al. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure. Circulation. 2009;119:2781\u20138.","journal-title":"Circulation"},{"key":"309_CR26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehs196","volume":"34","author":"E Erdmann","year":"2013","unstructured":"Erdmann E, Semigran MJ, Nieminen MS, et al. Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure. Eur Heart J. 2013;34:57\u201367.","journal-title":"Eur Heart J"},{"key":"309_CR27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s40138-014-0040-z","volume":"2","author":"PD Levy","year":"2014","unstructured":"Levy PD, Laribi S, Mebazaa A. Vasodilators in acute heart failure: review of the latest studies. Curr Emerg Hosp Med Rep. 2014;2:126\u201332.","journal-title":"Curr Emerg Hosp Med Rep"},{"key":"309_CR28","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/eurjhf\/hfs093","volume":"14","author":"M Gheorghiade","year":"2012","unstructured":"Gheorghiade M, Greene SJ, Filippatos G, et al. Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes. Eur J Heart Fail. 2012;14:1056\u201366.","journal-title":"Eur J Heart Fail"},{"key":"309_CR29","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/nprot.2008.138","volume":"3","author":"P Pacher","year":"2008","unstructured":"Pacher P, Nagayama T, Mukhopadhyay P, Batkai S, Kass DA. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc. 2008;3:1422\u201334.","journal-title":"Nat Protoc"},{"key":"309_CR30","doi-asserted-by":"crossref","first-page":"H124","DOI":"10.1152\/ajpheart.00108.2013","volume":"305","author":"T Radovits","year":"2013","unstructured":"Radovits T, Olah A, Lux A, et al. Rat model of exercise-induced cardiac hypertrophy: hemodynamic characterization using left ventricular pressure-volume analysis. Am J Physiol Heart Circ Physiol. 2013;305:H124\u201334.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"309_CR31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1172\/JCI114734","volume":"86","author":"SE Litwin","year":"1990","unstructured":"Litwin SE, Raya TE, Anderson PG, Daugherty S, Goldman S. Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle. J Clin Invest. 1990;86:481\u20138.","journal-title":"J Clin Invest"},{"key":"309_CR32","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1152\/physrev.2001.81.4.1461","volume":"81","author":"LH Snoeckx","year":"2001","unstructured":"Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS, Van Der Vusse GJ. Heat shock proteins and cardiovascular pathophysiology. Physiol Rev. 2001;81:1461\u201397.","journal-title":"Physiol Rev"},{"key":"309_CR33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315\u2013424.","journal-title":"Physiol Rev"},{"key":"309_CR34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tips.2014.05.003","volume":"35","author":"R Lukowski","year":"2014","unstructured":"Lukowski R, Krieg T, Rybalkin SD, Beavo J, Hofmann F. Turning on cGMP-dependent pathways to treat cardiac dysfunctions: boom, bust, and beyond. Trends Pharmacol Sci. 2014;35:404\u201313.","journal-title":"Trends Pharmacol Sci"},{"key":"309_CR35","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/ndt\/gfs391","volume":"28","author":"L Fang","year":"2013","unstructured":"Fang L, Radovits T, Szabo G, Mozes MM, Rosivall L, Kokeny G. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3\u2032,5\u2032 guanosine monophosphate (cGMP) level in podocytes. Nephrol Dial Transplant. 2013;28:1751\u201361.","journal-title":"Nephrol Dial Transplant"},{"key":"309_CR36","doi-asserted-by":"crossref","first-page":"12364","DOI":"10.1016\/S0021-9258(18)63867-0","volume":"264","author":"P Hamet","year":"1989","unstructured":"Hamet P, Pang SC, Tremblay J. Atrial natriuretic factor-induced egression of cyclic guanosine 3\u2032:5\u2032-monophosphate in cultured vascular smooth muscle and endothelial cells. J Biol Chem. 1989;264:12364\u20139.","journal-title":"J Biol Chem"},{"key":"309_CR37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2013.01.031","volume":"60","author":"S Koka","year":"2013","unstructured":"Koka S, Das A, Salloum FN, Kukreja RC. Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia\/reperfusion injury in type 2 diabetic mice. Free Radic Biol Med. 2013;60:80\u20138.","journal-title":"Free Radic Biol Med"},{"key":"309_CR38","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"H Bugger","year":"2014","unstructured":"Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014;57:660\u201371.","journal-title":"Diabetologia"},{"key":"309_CR39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00395-008-0715-2","volume":"103","author":"S Linthout Van","year":"2008","unstructured":"Van Linthout S, Seeland U, Riad A, et al. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol. 2008;103:319\u201327.","journal-title":"Basic Res Cardiol"},{"key":"309_CR40","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","volume":"51","author":"L Cai","year":"2002","unstructured":"Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes. 2002;51:1938\u201348.","journal-title":"Diabetes"},{"key":"309_CR41","doi-asserted-by":"crossref","unstructured":"Beyer C, Zenzmaier C, Palumbo-Zerr K, et al. Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFbeta signalling. Ann Rheum Dis. 2014. doi: 10.1136\/annrheumdis-2013-204508 (Published ahead of print 23 February 2014).","DOI":"10.1136\/annrheumdis-2013-204508"},{"key":"309_CR42","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/ndt\/gfn115","volume":"23","author":"S Wang","year":"2008","unstructured":"Wang S, Mitu GM, Hirschberg R. Osmotic polyuria: an overlooked mechanism in diabetic nephropathy. Nephrol Dial Transplant. 2008;23:2167\u201372.","journal-title":"Nephrol Dial Transplant"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-015-0309-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T07:39:59Z","timestamp":1748677199000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cardiab.com\/content\/14\/1\/145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,31]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["309"],"URL":"https:\/\/doi.org\/10.1186\/s12933-015-0309-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,31]]},"article-number":"145"}}